Marshall Wace, LLP Mersana Therapeutics, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.0 - $4.45 $275,192 - $612,302	137,596 Added 358.02%	176,029 $353,000
Q1 2024 May 15, 2024	SELL	$2.16 - $5.94 $257,832 - $709,039	-119,367 Reduced 75.64%	38,433 $172,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $2.71 Million - $9.98 Million	-2,553,510 Reduced 94.18%	157,800 $200,000
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $660,968 - $2.05 Million	214,600 Added 8.6%	2,711,310 $8.92 Million
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $109,096 - $191,463	-27,274 Reduced 1.08%	2,496,710 $10.3 Million
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $11.3 Million - $15.7 Million	1,995,516 Added 377.6%	2,523,984 $14.8 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $2.45 Million - $4.23 Million	528,468 New	528,468 $3.57 Million
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $92,774 - $163,335	-32,667 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $122,174 - $216,582	32,667 New	32,667 $130,000
Q4 2021 Feb 14, 2022	SELL	$5.48 - $9.86 $2.11 Million - $3.79 Million	-384,736 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $3.12 Million - $5.28 Million	364,891 Added 1838.7%	384,736 $3.63 Million
Q2 2021 Aug 13, 2021	SELL	$13.28 - $18.07 $1.76 Million - $2.39 Million	-132,265 Reduced 86.95%	19,845 $269,000
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $811,613 - $1.41 Million	53,012 Added 53.49%	152,110 $2.46 Million
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $1.67 Million - $2.73 Million	99,098 New	99,098 $2.64 Million
Q4 2019 Feb 14, 2020	SELL	$1.45 - $6.73 $176,237 - $817,984	-121,543 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.54 - $4.2 $78,290 - $213,519	-50,838 Reduced 29.49%	121,543 $192,000
Q2 2019 Aug 14, 2019	BUY	$3.84 - $6.4 $559,257 - $932,096	145,640 Added 544.63%	172,381 $698,000
Q1 2019 May 14, 2019	BUY	$3.51 - $7.3 $93,860 - $195,209	26,741 New	26,741 $141,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $216M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account